Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers - A randomized controlled trial

被引:174
作者
MacDonald, NE
Halperin, SA
Law, BJ
Forrest, B
Danzig, LE
Granoff, DM
机构
[1] Univ Ottawa, Ottawa, ON, Canada
[2] Dalhousie Univ, Halifax, NS, Canada
[3] Univ Manitoba, Winnipeg, MB, Canada
[4] Chiron Corp, Chiron Vaccines, Emeryville, CA USA
[5] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1998年 / 280卷 / 19期
关键词
D O I
10.1001/jama.280.19.1685
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context.-Meningococcal polysaccharide vaccines are not used routinely in infants and toddlers, the groups at highest risk of invasive disease, because of poor immunologic responses to the Neisseria meningitidis serogroup C polysaccharide in these age groups. Meningococcal C conjugate vaccines offer the prospect of circumventing this problem. Objective.-To assess the immunogenicity and the induction of immunologic memory in toddlers by meningococcal C conjugate vaccine. Design.-A multicenter, randomized, observer-blinded controlled trial. Setting.-Urban and suburban family medicine or pediatric practices, Participants.-Two hundred eleven healthy toddlers aged 15 to 23 months. Intervention.-Two injections at 2 months apart of meningococcal C conjugate (group 1, n = 69), plain meningococcal polysaccharide (group 2, n = 72), or hepatitis B virus vaccine (group 3, n = 70). All toddlers received a follow-up dose of plain meningococcal polysaccharide vaccine 12 months later. Main Outcome Measures.-IgG meningococcal C anticapsular antibody concentrations determined by enzyme-linked immunosorbent assay and complement-mediated bactericidal antibody. Results.-In group 1, the magnitude of the IgG response to meningococcal C conjugate vaccine was more than 4-fold higher after dose 1 and more than 10-fold higher after dose 2 compared with meningococcal polysaccharide vaccine (group 2) (P<.001). Higher titers persisted in the meningococcal C conjugate group for at least 12 months (P<.001). Group 1, primed with meningococcal C conjugate, had 25-fold higher IgG responses to the meningococcal polysaccharide 1-year booster dose than the controls who had received hepatitis B virus vaccine initially and were given meningococcal polysaccharide vaccine 1 year later for the first time (P<.001). In contrast, group 2, primed with meningococcal polysaccharide, had a 2-fold lower response to the 1-year booster meningococcal polysaccharide dose than the hepatitis B virus control group (P=.006), Serum bactericidal responses paralleled the enzyme-linked immunosorbent assay responses. Conclusions.-Immunization of toddlers with meningococcal C conjugate vaccine induces high titers of anticapsular and bactericidal antibody. Furthermore, this vaccine induces immunologic memory to meningococcal C polysaccharide. In contrast, meningococcal polysaccharide vaccine is less immunogenic than the conjugate vaccine and also induces a hyporesponsive state that persists for at least 12 months.
引用
收藏
页码:1685 / 1689
页数:5
相关论文
共 23 条
  • [1] Amato Neto V, 1974, Rev Inst Med Trop Sao Paulo, V16, P149
  • [2] Conjugate meningococcal serogroup A and C vaccine: Reactogenicity and immunogenicity in United Kingdom infants
    Fairley, CK
    Begg, N
    Borrow, R
    Fox, AJ
    Jones, DM
    Cartwright, K
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) : 1360 - 1363
  • [3] IMMUNE-RESPONSE OF HUMAN INFANTS TO POLYSACCHARIDE VACCINES OF GROUP-A AND GROUP-C NEISSERIA-MENINGITIDIS
    GOLD, R
    LEPOW, ML
    GOLDSCHNEIDER, I
    GOTSCHLICH, EC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1977, 136 : S31 - S35
  • [4] KINETICS OF ANTIBODY-PRODUCTION TO GROUP-A AND GROUP-C MENINGOCOCCAL POLYSACCHARIDE VACCINES ADMINISTERED DURING THE 1ST 6 YEARS OF LIFE - PROSPECTS FOR ROUTINE IMMUNIZATION OF INFANTS AND CHILDREN
    GOLD, R
    LEPOW, ML
    GOLDSCHNEIDER, I
    DRAPER, TF
    GOTSCHLICH, EC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (05) : 690 - 697
  • [5] HUMAN IMMUNITY TO MENINGOCOCCUS .I. ROLE OF HUMORAL ANTIBODIES
    GOLDSCHNEIDER, I
    GOTSCHLICH, EC
    ARTENSTEIN, MS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (06) : 1307 - +
  • [6] IMMUNOGENICITY OF GROUP-A AND GROUP-C MENINGOCOCCAL POLYSACCHARIDES IN HUMAN INFANTS
    GOLDSCHNEIDER, I
    LEPOW, ML
    GOTSCHLICH, EC
    MAUCK, FT
    BACHL, F
    RANDOLPH, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1973, 128 (06) : 769 - 776
  • [7] Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination
    Granoff, DM
    Gupta, RK
    Belshe, RB
    Anderson, EL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (03) : 870 - 874
  • [8] A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses
    Granoff, DM
    Maslanka, SE
    Carlone, GM
    Plikaytis, BD
    Santos, GF
    Mokatrin, A
    Raff, HV
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (04) : 479 - 485
  • [9] ANTIBODY-RESPONSES TO THE CAPSULAR POLYSACCHARIDE OF NEISSERIA-MENINGITIDIS SEROGROUP-B IN PATIENTS WITH MENINGOCOCCAL DISEASE
    GRANOFF, DM
    KELSEY, SK
    BIJLMER, HA
    VANALPHEN, L
    DANKERT, J
    MANDRELL, RE
    AZMI, FH
    SCHOLTEN, RJPM
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (05) : 574 - 582
  • [10] MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine
    Granoff, DM
    McHugh, YE
    Raff, HV
    Mokatrin, AS
    VanNest, GA
    [J]. INFECTION AND IMMUNITY, 1997, 65 (05) : 1710 - 1715